Published in PLoS One on September 25, 2013
Back by Popular Demand: A Narrative Review on the History of Food Addiction Research. Yale J Biol Med (2015) 0.83
Food addiction and its impact on weight-based stigma and the treatment of obese individuals in the U.S. and Australia. Nutrients (2014) 0.81
What Is Culinary Medicine and What Does It Do? Popul Health Manag (2015) 0.78
Food Addiction Beliefs Amongst the Lay Public: What Are the Consequences for Eating Behaviour? Curr Addict Rep (2017) 0.76
Are certain foods addictive? Front Psychiatry (2014) 0.76
Low-income women's conceptualizations of food craving and food addiction. Eat Behav (2015) 0.76
Incorporating food addiction into disordered eating: the disordered eating food addiction nutrition guide (DEFANG). Eat Weight Disord (2016) 0.76
Believing in food addiction: Helpful or counterproductive for eating behavior? Obesity (Silver Spring) (2016) 0.75
Belief in Food Addiction and Obesity-Related Policy Support. PLoS One (2016) 0.75
Perceptions of the causes of eating disorders: a comparison of individuals with and without eating disorders. J Eat Disord (2015) 0.75
Food addiction and obesity: unnecessary medicalization of hedonic overeating. Nat Rev Endocrinol (2017) 0.75
The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med (2009) 7.48
Can food be addictive? Public health and policy implications. Addiction (2011) 6.27
Public health: The toxic truth about sugar. Nature (2012) 6.24
"A disease like any other"? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am J Psychiatry (2010) 6.22
The impact of food prices on consumption: a systematic review of research on the price elasticity of demand for food. Am J Public Health (2009) 3.94
Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci (2010) 3.48
Issues for DSM-V: should obesity be included as a brain disorder? Am J Psychiatry (2007) 2.48
Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci (2012) 2.26
Further developments in the neurobiology of food and addiction: update on the state of the science. Nutrition (2012) 1.62
The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction. Nat Neurosci (2012) 1.33
The stigma of obesity in the general public and its implications for public health - a systematic review. BMC Public Health (2011) 1.13
Public opinion about laws to prohibit weight discrimination in the United States. Obesity (Silver Spring) (2010) 1.06
Obesity and public policy. Annu Rev Clin Psychol (2012) 1.03
New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier? Pharmacol Biochem Behav (2010) 0.99
Expanding applications of deep brain stimulation: a potential therapeutic role in obesity and addiction management. Acta Neurochir (Wien) (2011) 0.96
Internet marketing of bariatric surgery: contemporary trends in the medicalization of obesity. Soc Sci Med (2005) 0.91
The medicalization of compulsive buying. Soc Sci Med (2004) 0.88
Should overeating and obesity be classified as an addictive disorder in DSM-5? Curr Pharm Des (2011) 0.85
The neurobiology of overeating. Treating overweight individuals should make use of neuroscience research, but not at the expense of population approaches to diet and lifestyle. EMBO Rep (2012) 0.85
"Not all my fault": genetics, stigma, and personal responsibility for women with eating disorders. Soc Sci Med (2012) 0.84
Rationale and consequences of reclassifying obesity as an addictive disorder: neurobiology, food environment and social policy perspectives. Physiol Behav (2012) 0.83
Food industry front groups and conflicts of interest: the case of Americans Against Food Taxes. Public Health Nutr (2012) 0.82
On the biomedicalization of alcoholism. Theor Med Bioeth (2009) 0.81
Opioid overdose deaths can occur in patients with naltrexone implants. Med J Aust (2007) 4.86
Exploring conditions under which it may be ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception. Addiction (2012) 3.99
Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet (2007) 3.97
Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. Addiction (2012) 3.91
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet (2013) 3.65
The demise of a planned randomised controlled trial in an urban Aboriginal medical service. Med J Aust (2002) 3.41
Ethical concerns in the community about technologies to extend human life span. Am J Bioeth (2009) 2.87
The long-term effectiveness of brief interventions for unsafe alcohol consumption: a 10-year follow-up. Addiction (2002) 2.61
Does research into sensitive areas do harm? Experiences of research participation after a child's diagnosis with Ewing's sarcoma. Med J Aust (2002) 2.27
Is child sexual abuse declining? Evidence from a population-based survey of men and women in Australia. Child Abuse Negl (2003) 2.23
Proposals to trial deep brain stimulation to treat addiction are premature. Addiction (2011) 2.17
The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS One (2013) 2.17
Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med (2007) 2.10
Patterns of antipsychotic medication use in Australia 2002-2007. Aust N Z J Psychiatry (2010) 1.86
The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction (2012) 1.83
The enhancement use of neuropharmaceuticals: more scepticism and caution needed. Addiction (2010) 1.58
From "our world" to the "real world": Exploring the views and behaviour of policy-influential Australian public health researchers. Soc Sci Med (2011) 1.55
Per capita alcohol consumption in Australia: will the real trend please step forward? Med J Aust (2010) 1.54
Multiple genetic tests for susceptibility to smoking do not outperform simple family history. Addiction (2009) 1.51
Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception? Addiction (2012) 1.49
Sociodemographic correlates of antidepressant utilisation in Australia. Med J Aust (2009) 1.47
Survivorship care after breast cancer treatment--experiences and preferences of Australian women. Breast (2011) 1.43
Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend (2010) 1.40
UK classification of cannabis: is a change needed and why? Lancet (2007) 1.38
The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction (2014) 1.35
Smart drugs "as common as coffee": media hype about neuroenhancement. PLoS One (2011) 1.27
Substance use and the adolescent brain: a toxic combination? J Psychopharmacol (2007) 1.23
A longitudinal study of the association of adolescent polydrug use, alcohol use and high school non-completion. Addiction (2015) 1.16
Patient barriers to optimal cancer pain control. Psychooncology (2003) 1.14
Hormone replacement therapy: to use or not to use? Med J Aust (2003) 1.12
Randomised controlled trial of a service brokerage intervention for ex-prisoners in Australia. Contemp Clin Trials (2013) 1.09
Reaching "an audience that you would never dream of speaking to": influential public health researchers' views on the role of news media in influencing policy and public understanding. J Health Commun (2013) 1.08
How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality? Aust N Z J Psychiatry (2006) 1.08
The association between four citation metrics and peer rankings of research influence of Australian researchers in six fields of public health. PLoS One (2011) 1.07
'Occasional' and 'social' smokers: potential target groups for smoking cessation campaigns? Aust N Z J Public Health (2006) 1.05
Galvanizers, guides, champions, and shields: the many ways that policymakers use public health researchers. Milbank Q (2011) 1.04
Transitions into informal caregiving and out of paid employment of women in their 50s. Soc Sci Med (2008) 1.02
Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention. Addiction (2009) 1.01
Cigarette tax and public health: what are the implications of financially stressed smokers for the effects of price increases on smoking prevalence? Addiction (2010) 1.01
Caveolin-1 is required for lateral line neuromast and notochord development. J Cell Sci (2007) 1.00
Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety. Drug Alcohol Rev (2012) 1.00
The effect of a reduction in heroin supply on fatal and non-fatal drug overdoses in New South Wales, Australia. Med J Aust (2005) 1.00
Why do they do it? A pilot study towards understanding participant motivation and experience in a large genetic epidemiological study of endometriosis. Community Genet (2007) 0.99
Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia. Contraception (2009) 0.99
Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer. Breast Cancer Res (2014) 0.98
Survivorship care after breast cancer: follow-up practices of Australian health professionals and attitudes to a survivorship care plan. Asia Pac J Clin Oncol (2010) 0.97
Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. Addiction (2010) 0.97
Identifying trustworthy experts: how do policymakers find and assess public health researchers worth consulting or collaborating with? PLoS One (2012) 0.97
Is there evidence of 'hardening' among Australian smokers between 1997 and 2007? Analyses of the Australian National Surveys of Mental Health and Well-Being. Aust N Z J Psychiatry (2010) 0.96
Improving diet, physical activity and other lifestyle behaviours using computer-tailored advice in general practice: a randomised controlled trial. Int J Behav Nutr Phys Act (2012) 0.96
Assessing the wisdom of funding DrinkWise. Med J Aust (2006) 0.95
Pregnancy losses in young Australian women: findings from the Australian Longitudinal Study on Women's Health. Womens Health Issues (2008) 0.95
Tailoring access to high cost, genetically targeted drugs. Med J Aust (2005) 0.94
Should burden of disease estimates include cannabis use as a risk factor for psychosis? PLoS Med (2009) 0.94
What are the major drivers of prevalent disability burden in young Australians? Med J Aust (2011) 0.92
Making new choices about antidepressants in Australia: the long view 1975-2002. Med J Aust (2004) 0.92
Alcohol policy reform in Australia: what can we learn from the evidence? Med J Aust (2010) 0.91
Should Australia lift its ban on low nitrosamine smokeless tobacco products? Med J Aust (2008) 0.91
Advocates need to show compulsory treatment of opioid dependence is effective, safe and ethical. Bull World Health Organ (2013) 0.91
A randomized controlled trial of a standardized educational intervention for patients with cancer pain. J Pain Symptom Manage (2010) 0.89
Increasing cancer mortality among opioid-dependent persons in Australia: a new public health challenge for a disadvantaged population. Aust N Z J Public Health (2011) 0.89
Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations. J Mol Med (Berl) (2003) 0.88
The genetics of nicotine addiction liability: ethical and social policy implications. Addiction (2008) 0.88
Knockdown of zebrafish crim1 results in a bent tail phenotype with defects in somite and vascular development. Mech Dev (2006) 0.87
The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Addiction (2010) 0.87
The "alcopops" tax: heading in the right direction. Med J Aust (2009) 0.86
Is the socioeconomic gap in childhood exposure to secondhand smoke widening or narrowing? Tob Control (2012) 0.86
Impact of cognitive and physical impairment on carer burden and quality of life. Qual Life Res (2007) 0.86
Public attitudes towards the acceptability of using drugs to treat depression and ADHD. Aust N Z J Psychiatry (2012) 0.85
Alcohol sales data are essential for good public policies towards alcohol. Med J Aust (2008) 0.85
The neurobiology of overeating. Treating overweight individuals should make use of neuroscience research, but not at the expense of population approaches to diet and lifestyle. EMBO Rep (2012) 0.85
The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug Alcohol Rev (2013) 0.85
Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs. Front Psychiatry (2013) 0.85
Is the "alcopops" tax working? Probably yes but there is a bigger picture. Med J Aust (2011) 0.85
A cladding-pumped, tunable holmium doped fiber laser. Opt Express (2013) 0.85
Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Educ Couns (2012) 0.85
Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model. J Neurooncol (2007) 0.84
Psychological distress is associated with tobacco smoking and quitting behaviour in the Australian population: evidence from national cross-sectional surveys. Aust N Z J Psychiatry (2010) 0.84
Supportive care needs and preferences of lung cancer patients: a semi-structured qualitative interview study. Support Care Cancer (2014) 0.83
ask for it: development of a health advocacy intervention for adults with intellectual disability and their general practitioners. Health Promot Int (2004) 0.83
Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptability of drug treatment for depression and ADHD. BMC Psychiatry (2014) 0.83
Suppression and overexpression of adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) influences zebrafish embryo development: a possible role for AHCYL1 in inositol phospholipid signaling. J Biol Chem (2006) 0.83
Smokeless tobacco use in Australia. Drug Alcohol Rev (2009) 0.83
Depression and psychological distress in tobacco smokers and people with cannabis dependence in the National Survey of Mental Health and Wellbeing. Med J Aust (2011) 0.83
Would vaccination against nicotine be a cost-effective way to prevent smoking uptake in adolescents? Addiction (2012) 0.83
A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers. Melanoma Res (2014) 0.82
The value and pitfalls of speculation about science and technology in bioethics: the case of cognitive enhancement. Med Health Care Philos (2014) 0.82
Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer. ANZ J Surg (2015) 0.82
Utilization of anti-Parkinson drugs in Australia: 1995-2009. Pharmacoepidemiol Drug Saf (2011) 0.82
Anticipating the use of life extension technologies. EMBO Rep (2010) 0.82
Five genetic variants associated with prostate cancer. N Engl J Med (2008) 0.81
Sexual abuse in childhood and physical and mental health in adulthood: an Australian population study. Arch Sex Behav (2007) 0.81
The demise of a planned randomised controlled trial in an urban Aboriginal medical service. Med J Aust (2002) 0.81
Public attitudes in Australia towards the claim that addiction is a (brain) disease. Drug Alcohol Rev (2014) 0.81
Ethical, social, and personal implications of extended human lifespan identified by members of the public. Rejuvenation Res (2009) 0.81
Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals. EMBO Rep (2011) 0.81
Why we need tobacco sales data for good tobacco control. Med J Aust (2010) 0.81